Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

Published:2012-09 Issue:7 Volume:114 Page:940-946
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Kalincik T.,Horakova D.,Dolezal O.,Krasensky J.,Vaneckova M.,Seidl Z.,Havrdova E.

Funder

Czech Ministry of Education

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference21 articles.

1. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials;Bates;Neurology,2011

2. Combination therapy in multiple sclerosis;Conway;Lancet Neurol,2010

3. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis;Richert;Mult Scler,2001

4. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy;Navarro;J Neuroimmunol,2006

5. Effects of IV methylprednisolone on brain atrophy in relapsing–remitting MS;Zivadinov;Neurology,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on combination therapies for multiple sclerosis: where are we now?;Expert Review of Neurotherapeutics;2023-12-02

2. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society;Revue Neurologique;2020-12

3. Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year employment status in multiple sclerosis patients;Journal of the Neurological Sciences;2018-05

4. Thérapeutiques et prise en charge de la sclérose en plaques;La Sclérose en Plaques - Clinique et Thérapeutique;2017

5. Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?;Multiple Sclerosis Journal;2016-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3